Nanomedicine News

RSS

Two Drugs Within Specially Designed Mesoporous Silica Nanoparticle Can Shrink Human Pancreas Tumors

Scientists at UCLA’s California NanoSystems Institute and Jonsson Comprehensive Cancer Center have combined their nanotechnology expertise to create a new treatment that may solve some of the problems of using chemotherapy to treat pancreatic cancer.

From University of California, Los Angeles 24 Mar 2015

Global Nanotechnology in Medical Devices Market Forecast to Reach $8.5 Billion by 2019

Global Nanotechnology in Medical Devices Market is was valued at around $5 Billion in 2014 and expected to reach around $8.5 Billion by 2019 with a CAGR of around 11-12% during the forecast period 2014 - 2019 - Says a New Research Available at RnRMarketResearch.com

24 Mar 2015

MagForce Announces Installation of NanoActivator at Cologne University Hospital

MagForce AG, a leading medical device company in the field of nanomedicine focused on oncology, today announced the installation of the fourth NanoActivator(R).

23 Mar 2015

Cerulean Reports Top-Line Results from CRLX101-Avastin Combination Phase 1b/2 Trial for Relapsed Renal Cell Carcinoma

Cerulean Pharma Inc., a leader in Dynamic Tumor Targeting™, today announced that a Phase 1b/2 trial of its lead nanoparticle-drug conjugate, CRLX101, in combination with Avastin® in relapsed renal cell carcinoma (RCC) achieved its primary endpoint of at least 50% of patients achieving four months of progression free survival (PFS).

20 Mar 2015

Nanotechnology and Transdermal Drug Delivery to Treat Acne

Acne, a scourge of adolescence, may be about to meet its ultra high-tech match. By using a combination of ultrasound, gold-covered particles and lasers, researchers from UC Santa Barbara and the private medical device company Sebacia have developed a targeted therapy that could potentially lessen the frequency and intensity of breakouts, relieving acne sufferers the discomfort and stress of dealing with severe and recurring pimples.

20 Mar 2015

Coating Scaffold with Self-Assembling Nanofibers Decreases Inflammation

A new technique to create tissue-engineered bladders has been shown to decrease scarring and significantly increase tissue growth. The bladders are produced using scaffolds coated with anti-inflammatory peptides.

19 Mar 2015

AACR Annual Meeting: Three Abstracts on BIND Therapeutics’s Accurins to be Presented

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, today announced the online availability of three abstracts that will be presented during the April 18-22 American Association of Cancer Research (AACR) Annual Meeting in Philadelphia.

19 Mar 2015

LamdaGen Opens Wholly-Owned Subsidiary, LamdaGen Nanotechnology Taiwan

LamdaGen Corporation, a nano-technology platform company that provides LSPR based plasmonic sensors and systems for In Vitro Diagnostics (IVD), announced the opening of a wholly-owned subsidiary, LamdaGen Nanotechnology Taiwan Co., LTD. (LamdaGen Taiwan).

19 Mar 2015

Global Forecast Report on Nanotechnology in Medical Devices Market

According to a new market research report "Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019", published by MarketsandMarkets, the Nanotechnology in Medical Devices Market is was valued at around $5 Billion in 2014 and expected to reach around $8.5 Billion by 2019 with a CAGR of around 11-12% during the forecast period 2014 - 2019.

19 Mar 2015

UTHSC CTRC Begins Nanotherapy Brain Cancer Trial in Humans

David Williams is the first human being ever to have a new radiation treatment implanted in the center of his brain tumor.

18 Mar 2015

Nanomedicine News

Two Drugs Within Specially Designed Mesoporous Silica Nanoparticle Can Shrink Human Pancreas Tumors

Global Nanotechnology in Medical Devices Market Forecast to Reach $8.5 Billion by 2019

MagForce Announces Installation of NanoActivator at Cologne University Hospital

Cerulean Reports Top-Line Results from CRLX101-Avastin Combination Phase 1b/2 Trial for Relapsed Renal Cell Carcinoma

Nanotechnology and Transdermal Drug Delivery to Treat Acne

Coating Scaffold with Self-Assembling Nanofibers Decreases Inflammation

AACR Annual Meeting: Three Abstracts on BIND Therapeutics’s Accurins to be Presented

LamdaGen Opens Wholly-Owned Subsidiary, LamdaGen Nanotechnology Taiwan

Global Forecast Report on Nanotechnology in Medical Devices Market

UTHSC CTRC Begins Nanotherapy Brain Cancer Trial in Humans

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials